Alpha Cognition, Inc. (ACOG)
8.24
+0.09
(+1.10%)
USD |
NASDAQ |
Nov 06, 10:31
Alpha Cognition EPS Diluted (Quarterly) : -0.4037 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4037 |
| March 31, 2026 | -0.3208 |
| December 31, 2025 | -0.3153 |
| September 30, 2025 | -0.0816 |
| June 30, 2025 | -0.8239 |
| March 31, 2025 | -0.1077 |
| December 31, 2024 | -0.5051 |
| September 30, 2024 | -0.3085 |
| June 30, 2024 | -0.352 |
| March 31, 2024 | -0.8707 |
| December 31, 2023 | -1.347 |
| September 30, 2023 | -0.8425 |
| June 30, 2023 | -0.7445 |
| March 31, 2023 | -0.612 |
| Date | Value |
|---|---|
| December 31, 2022 | -1.672 |
| September 30, 2022 | -0.7627 |
| June 30, 2022 | -1.104 |
| March 31, 2022 | -1.076 |
| December 31, 2021 | -1.622 |
| September 30, 2021 | -2.332 |
| March 31, 2021 | -6.888 |
| January 31, 2021 | -13.38 |
| January 31, 2020 | -0.1614 |
| October 31, 2019 | -0.3507 |
| July 31, 2019 | -1.033 |
| April 30, 2019 | -0.1475 |
| January 31, 2019 | -0.2361 |
| October 31, 2018 | -3.066 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.790M |
| Revenue (Quarterly) | 6.093M |
| Total Expenses (Quarterly) | 14.88M |
| Enterprise Value | 136.02M |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | -144.3% |
| Earnings Yield | -13.61% |
| Normalized Earnings Yield | -15.58 |